Anavex Life Sciences Corp (AVXL)

[falconer66a]

The use of Anavex molecules for diseases beyond the three currently in consideration (Alzheimer’s, Parkinson’s, and Rett) is a fuzzy proposition — but one that should be investigated.

The multiple ways Anavex molecules restore (or create) cellular homeostasis, proper, normalized function, are still being parsed out. The re-connection of disconnected rough endoplasmic reticula to mitochondria, which is the primary mechanism (but not the only one) that allows A2-73 to suppress Alzheimer’s symptoms, is now well understood and characterized. Mitochondrial dysfunction is almost universally common among Central Nervous System diseases, and many others.

In reading the many obscure technical reports on Anavex molecules, so far pretty much just in diseased rats and mice, it’s clear the molecules do restorative things heretofore never imagined or envisioned; far beyond just the ER-mitochondrial phenomena. The preliminary murine data showing efficacies against other CNS diseases (such as the one I have, hereditary spastic paraplegia), including cancers, cardiovascular conditions, and psychiatric anomalies are just stunning. The data look too good to be true. Anavex molecules appear to be “cure alls,” dare I say (well, “treat alls”).

Now some real, hard clinical data, both murine and human, will need to be generated to determine with some precision just what Anavex pipeline drugs (or their emerging analogues) can effectively treat what diseases at what stages at what dosages at what durations. The stuff is safe, with virtually no side effects. Throw Anavex molecules at diseased animals and see what happens. Based upon the unique, facilitating, restorative biology of Anavex drugs, I will not be surprised to learn in the coming year of all sorts of potential, new treatment applications.

Lastly, as I’ve so rather frequently mentioned, the best and most rewarding use of Anavex technologies may prove to be age-related disease prophylaxis. Pop 500mg of Anavex 3-71 everyday with breakfast, and chances of age-related disease plummets. For genetically defective infants, use the drug to epigenetically suppress bad genes.

Gonna be exciting to watch how this plays out.